About FHH
History
Organizational structure
- Standing Committee
- Sub-Committee
Ex-Chairperson
Members List
Photos
Bulletin Board
Information
Notice
Short Communications
Adulterated Herbal Medicine
- Purpose
- Database
Herbs World Wide
Meetings
Standing Committee
International Symposium
Meeting Materials
Sub-Committee 1
Sub-Committee 2
Sub-Committee 3
FHH Previous Meeting
Projects
Pharmacopoeia
- Purpose
- Products
- Terminology
- Link
FHH Atlas
FHH RMPM
- Purpose
- Results
- Distribution
COVID-19
COVID-19
Link
Link
Sign In
About FHH
History
Organizational structure
Ex-Chairperson
Members List
Photos
History
History
Organizational structure
Ex-Chairperson
Members List
Photos
Meetings
게시물 검색폼
Keyword
ADR
Adulteration
Aflatoxin
Benzopyrene
CITES
Collaboration
DNA
Efficacy
GA(C)P
GMP
Guideline
Heavy metal
Microorganism
Pesticide
Pharmacopoeia
Processing
Quality
Reference substance
Regulation
Registration
Safety
Sulfur dioxide
Surveillance
Training
Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
[Total :
709
]
No.
Code
Title
Speaker
Country
331
5th FIS 09 (2014)
Preparation and Testing of TCM Reference Materials
Jiandong YU
China
330
5th FIS 08 (2014)
Global Herbal Medicines Standard Initiative by United States Pharmacopoeia
Jie LIU
China
329
5th FIS 07 (2014)
Comparison between Chinese and Western Approaches to Medicine
Alex LAW
Singapore
328
5th FIS 06 (2014)
Regulation of Chinese Medicine in Hong Kong
Alice WONG
Hong Kong SAR, China
327
5th FIS 05 (2014)
Hong Kong Chinese Materia Medica Standards (HKCMMS)
Polly CHAN
Hong Kong SAR, China
326
5th FIS 04 (2014)
Research and Development of TCM Quality Control Standard
Jiangyong YU
China
325
5th FIS 03 (2014)
Adulteration and Authentication of Herbal Medicines
Chee Leong KEE
Singapore
324
5th FIS 02 (2014)
Adulterated Sexual Performance Enhancers with PDE-5 Inhibitors and Their Analogues
Hwee-Ling KOH
Singapore
323
5th FIS 01 (2014)
Pharmacovigilance of Natural Health Products in Canada Case Studies: 1) Ibogaine use in Detoxification and 2) Melatonin use in Pediatric Patients
Duc VU
Canada
37
38
39
40
41
42
43
44
45